| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/21/2009 | US20090130695 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase; antitumor agents, anticancer agents |
| 05/21/2009 | US20090130693 Novel biomarkers for diagnosis and/or prognosis of neoplasias in animals |
| 05/21/2009 | US20090130692 Use of microproteins as tryptase |
| 05/21/2009 | US20090130681 21132, a Human G-protein coupled receptor family member and uses therefor |
| 05/21/2009 | US20090130676 Interaction trap systems for detecting protein interactions |
| 05/21/2009 | US20090130675 Genes Involved in the Biosynthesis of Thiocoraline and Heterologous Production of Same |
| 05/21/2009 | US20090130674 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 05/21/2009 | US20090130191 Osteoclast Growth Inhibitor, Oral Composition, and Preventive or Therapeutic Agent for Bone Diseases, Containing Liposome-Encapsulated Lactoferrin |
| 05/21/2009 | US20090130145 Vaccine |
| 05/21/2009 | US20090130136 Chondroitin Sulphate a Binding Domains |
| 05/21/2009 | US20090130134 T CD4+ Epitopes of Type I and II Latency Antigens of the Epstein-Barr Virus, Which Can Be Recognized by the majority of individuals in the caucasian populations and applications thereof |
| 05/21/2009 | US20090130133 Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof |
| 05/21/2009 | US20090130132 Anti-caveolin-1 polyclonal antibody, and antigen peptide sequence and method for preparing the same |
| 05/21/2009 | US20090130130 Mutant allergen(s) |
| 05/21/2009 | US20090130126 Dna expression vectors |
| 05/21/2009 | US20090130122 Methods for treating rheumatoid arthritis using IL-17 antagonists |
| 05/21/2009 | US20090130115 Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use |
| 05/21/2009 | US20090130114 Wise binding agents and epitopes |
| 05/21/2009 | US20090130112 Spatial for altering cell proliferation |
| 05/21/2009 | US20090130107 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 05/21/2009 | US20090130095 Composition comprising tumor necrosis factor (CD40) specific immunoglobulin for treatment and prevention of autoimmune diseases |
| 05/21/2009 | US20090130060 Modified Vitamin K Dependent Polypeptides |
| 05/20/2009 | EP2060634A1 Structure protein of adeno-associated virus with amended antigenity, production and application thereof |
| 05/20/2009 | EP2060631A2 Characterization of granulocytic ehrlichia and methods of use |
| 05/20/2009 | EP2060630A2 PCA3, PCA3 genes, and methods of use |
| 05/20/2009 | EP2060586A1 New synthetic arginine substituted peptides and their use |
| 05/20/2009 | EP2060585A2 Gene regulatory peptides |
| 05/20/2009 | EP2060584A1 Method for the production of proteins with chemically functionalized N-termini |
| 05/20/2009 | EP2060583A1 Identification of tumor-associated markers for diagnosis and therapy |
| 05/20/2009 | EP2060582A1 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
| 05/20/2009 | EP2060581A1 Scaffold proteins for recombinant peptide aptamers |
| 05/20/2009 | EP2060266A1 Y4 selective receptor agonists for therapeutic interventions |
| 05/20/2009 | EP2060265A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 05/20/2009 | EP2059807A1 Diagnosing pneumococcal pneumonia |
| 05/20/2009 | EP2059606A2 Fusion peptide therapeutic compositions |
| 05/20/2009 | EP2059598A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity |
| 05/20/2009 | EP2059593A2 Treating or preventing cancers over-expressing reg4 or kiaa0101 |
| 05/20/2009 | EP2059534A1 Engineered anti-il-23p19 antibodies |
| 05/20/2009 | EP2059530A1 Method for the production of insulin-like growth factor-i |
| 05/20/2009 | EP2059528A2 Recombinant interferon-beta with enhanced biological activity |
| 05/20/2009 | EP2059527A2 Modified proteins |
| 05/20/2009 | EP2059526A2 Borrelia antigens |
| 05/20/2009 | EP2059525A1 Split-core-particles for the presentation of foreign molecules, especially for vaccine applications, and method for their production |
| 05/20/2009 | EP2059524A2 Aquaretic and natriuretic polypeptides lacking vasodilatory activity |
| 05/20/2009 | EP2059263A1 Use of light sensitive genes |
| 05/20/2009 | EP2059262A1 A dna vaccine for treating or preventing cervical cancer comprising a gene encoding hpv protein |
| 05/20/2009 | EP2059261A1 Method for the production of conjugates of insulin-like growth factor-i and poly(ethylene glycol) |
| 05/20/2009 | EP2059256A1 Immunogenic peptides and their use in immune disorders |
| 05/20/2009 | EP2059255A2 Hsv-1 and hsv-2 vaccines and methods of use thereof |
| 05/20/2009 | EP1928227A4 Transgenic plants with enhanced agronomic traits |
| 05/20/2009 | EP1656458B1 Human autism susceptibility gene and uses thereof |
| 05/20/2009 | EP1592789B1 Administration of transposon-based vectors to reproductive organs |
| 05/20/2009 | EP1562620B1 Modified cytokines for use in cancer therapy |
| 05/20/2009 | EP1341912B1 Method for the identification and isolation of binding polypeptides from combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
| 05/20/2009 | EP1330265B1 Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 05/20/2009 | EP1163260B1 Process for partitioning of proteins |
| 05/20/2009 | EP1078987B1 Method for examining central nervous system diseases and method for screening remedies |
| 05/20/2009 | CN101437958A Soybean plants having superior agronomic performance and methods for their production |
| 05/20/2009 | CN101437850A Anti-5T4 antibodies and uses thereof |
| 05/20/2009 | CN101437849A Insulin derivative |
| 05/20/2009 | CN101437848A Selective VPAC2 receptor peptide agonists |
| 05/20/2009 | CN101437847A Antibody-targeted cytokines for therapy |
| 05/20/2009 | CN101437846A Proteins, nucleic acids and medicaments |
| 05/20/2009 | CN101437845A Apoptosis methods, genes and proteins |
| 05/20/2009 | CN101437844A Polynucleotide encoding a maize herbicide resistance gene and methods for use |
| 05/20/2009 | CN101437843A Methods for breeding glyphosate resistant plants and compositions thereof |
| 05/20/2009 | CN101437842A Cupredoxin derived transport agents and methods of use thereof |
| 05/20/2009 | CN101437841A Virosome-like vesicles comprising gp41-derived antigens |
| 05/20/2009 | CN101437840A P15 hairpin constructs and use |
| 05/20/2009 | CN101437837A Protein folding |
| 05/20/2009 | CN101437540A Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 05/20/2009 | CN101437538A Modified adenovirus hexon protein and uses thereof |
| 05/20/2009 | CN101437534A Broad spectrum immune and antiviral gene modulation by oral interferon |
| 05/20/2009 | CN101437532A Phage derived antimicrobial activities |
| 05/20/2009 | CN101434960A Protective antigen mutant of Bacillus anthracis |
| 05/20/2009 | CN101434958A Method for preparing porcine alpha-interferon |
| 05/20/2009 | CN101434957A Recombinant human interferon alpha 2b DNA fragment and encoding protein |
| 05/20/2009 | CN101434955A Recombinant expression method of insect C-type lectin and use |
| 05/20/2009 | CN101434954A Chinese bee royal jelly main protein AccMRJP7 gene and encoding protein thereof |
| 05/20/2009 | CN101434654A Neutralizing antibody against HGF and neutralizing antibody binding to the same |
| 05/20/2009 | CN101434653A Preparation and detection kit for human ARMET protein monoclonal antibody |
| 05/20/2009 | CN101434652A Pyrethroid pesticide artificial antigen, antibody and preparation thereof |
| 05/20/2009 | CN101434651A Recombinant thymosin beta 4 two repeat protein and preparation thereof |
| 05/20/2009 | CN101434647A Epitope/peptide recognized by hla-a2402-restricted ep/cam-specific ctl and use of the same |
| 05/20/2009 | CN101434643A Method for extracting alcohol soluble protein in malt |
| 05/20/2009 | CN101433722A Fusions of cytokines and tumor targeting proteins |
| 05/20/2009 | CN101433715A Modified chimeric polypeptides with improved pharmacokinetic properties |
| 05/20/2009 | CN100489114C Low-cost production for peptides |
| 05/20/2009 | CN100489107C DNA transfection system for the generation of infectious influenza virus |
| 05/20/2009 | CN100489106C Monocdyledon plant cells and plants which synthesizes modified starch |
| 05/20/2009 | CN100489105C Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector |
| 05/20/2009 | CN100489102C T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 05/20/2009 | CN100489101C G-eGFP protein, preparation method, and application |
| 05/20/2009 | CN100489100C Sand sagebrush AdZFP1 transcription factor gene and its use in cultivation of drought enduring plant |
| 05/20/2009 | CN100489099C Method of imparting or controlling fertility by using fertility restoring gene for rice BT-male sterility cytoplasm and method of judging the existence of fertility restoring gene |
| 05/20/2009 | CN100489098C Goose B lymphocyte stimulating factor CDNA, and its cloning method and recombinant use |
| 05/20/2009 | CN100489097C Method for preparing protein using endogenetic angiogenesis inhibitive factor Arresten gene |
| 05/20/2009 | CN100489016C Method of extracting collagen and method of using collagen to prepare collagen protein |
| 05/20/2009 | CN100488984C Reducing immunogenicity of fusion proteins |
| 05/20/2009 | CN100488981C Proaerolysin containing protease activation sequences and its uses |